MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Treatment"

  • 2025 International Congress

    Comparative Efficacy and Safety of VMAT2 Inhibitors for Chorea in Huntington’s Disease: A Systematic Review and Meta-Analysis

    A. Abunamoos, M. Mustafa, F. Alnajjar, Y. Aljazi, K. Moghib, N. Hamam, M. Alghaniem (Amman, Jordan)

    Objective: To assess the safety and efficacy of vesicular monoamine transporter 2 (VMAT2) inhibitors (deutetrabenazine, tetrabenazine, valbenazine) in managing chorea in Huntington’s Disease (HD). Background:…
  • 2025 International Congress

    Adult-Onset Post-Pump Chorea: A Rare Manifestation Post-Cardiac Surgery in a Puerto Rican Patient

    E. Pérez-Luciano, C. Morfi-Pagán, D. Lozada-Figueroa, L. Surillo-Dahdah (Ponce, Puerto Rico)

    Objective: To report the first case of adult-onset post-pump chorea in Puerto Rico and raise awareness of our patient’s atypical age and onset of clinical…
  • 2025 International Congress

    Unraveling NKX2-1-related disorders: clinical, genetic, and neuroimaging insights from a global cohort

    JD. Ortigoza-Escobar, L. Nou-Fontanet, C. Ravelli, S. Balsells Mejia, E. Roman Schiffels, A. Innocenti, B. Villafuerte, A. Salazar, V. Quiroz, A. Sariego Jamardo, G. Bonato, A. Díaz-Gomez, A. Afenjar, C. Vilain, P. Dumke Dasilva, D. Garcia-Navas Nuñez, M. Krygier, MJ. Molnar, L. Milanowski, K. Ounap, M. Pauni, R. Borie, P. Vega, M. Villamil, S. Yilmaz, D. Zádori, M. Zawadzka, TS. Barakat, N. Sebastian, D. Natera Debenito, L. Soliani, CM. de Gusmao, G. Garone, N. Specchio, M. Carecchio, JC. Moreno, F. Magrinelli, D. Ebrahimi-Fakhari, C. Castiglioni, M. Kurian, JN. Carvalho, R. Pons, E. Flamand-Roze, D. Doummar (Barcelona, Spain)

    Objective: To analyze the clinical spectrum, genotype-phenotype correlations, and prognostic factors in NKX2-1-related disorders (NKX2-1-RD) through a multicenter study, providing insights for improved diagnosis and…
  • 2025 International Congress

    Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders

    S. Manohar, J. Jacobe, R. Berger, J. Jankovic, M. Hull (Houston, USA)

    Objective: We review the real-world prescribing practices and patient experiences with VMAT2 inhibitors in children. Background: Vesicular monoamine transporter 2 (VMAT2) inhibitors are often prescribed…
  • 2024 International Congress

    Shifting Paradigms In Huntington’s Disease Research: A Five-Year Scopus-Based Bibliometric Exploration

    RN. Surbakti, RK. Praja (Palangka Raya, Indonesia)

    Objective: This study aimed to investigate the shifting trends (2019-2024) in research on Huntington's disease (HD)based on bibliometric lens. Background: Huntington's disease is a movement…
  • 2024 International Congress

    Exploring the Impact of Mechanoacoustic Vibration Therapy on Mobility, Bone Density, and Postural Stability in Perimenopause Women with Huntington’s disease

    S. Devi, R. Chauhan (Narsan, India)

    Objective: This study aimed to investigate the effects of mechanoacoustic vibration therapy on mobility, bone mineral density (BMD), and postural instability in perimenopause  women with…
  • 2024 International Congress

    Patient and Caregiver Experiences with Huntington Disease: Emotions, Challenges, and Unmet Needs in the Patient Journey

    A. Peyser Levin, E. Kinjo, R. Ribalov, N. Chaijale, A. Yaari (Tel Aviv, Israel)

    Objective: To describe patients' emotional journey from symptom onset and diagnosis to current state and to identify challenges and unmet needs in Huntington disease (HD).…
  • 2024 International Congress

    Patient Reported Outcomes of Using a Chaplain Service in a Huntington’s Disease Clinic

    C. Marshall, W. Aamodt, J. Klapper, P. Cinicola, N. Kleinberg, A. Lasker (Philadelphia, USA)

    Objective: To better understand and describe the impact of providing spiritual care, in the form of a chaplain service, to patients being seen in a…
  • 2024 International Congress

    TeleHD: Feasibility, Validity and Value of Telemedicine in Huntington Disease

    J. Deliz, N. Lancki, D. Larson (CHICAGO, USA)

    Objective: To demonstrate the feasibility of conducting telemedicine visits, establish the validity and reliability of tele-administered motor/non-motor assessments, and determine the satisfaction of virtual visits…
  • 2024 International Congress

    Clonazepam as First-Line Therapy for Post-Hypoxic Chorea: A Case Report and Discussion

    G. Chu, R. Koshy, A. Maleki (moreno valley, USA)

    Objective: Reporting a rare case of generalized chorea in a 35-year-old female following cardiac arrest, which demonstrated rapid improvement with a short course of clonazepam.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 11
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley